Business Name: |
Suklenik LA MD |
Contact Person: |
LA Suklenik |
Address: |
13005 Southern Boulevard, Loxahatchee, Florida 33470 |
Phone Number: |
(561) 429-2106 |
Annual Revenue (USD): |
$500.000 to $999.999 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
6211110 |
Share This Business: |
|
Related Businesses: |
Jeffrey Kuger L Md - Loxahatchee, FL 33470 Srivastava Monika MD - Loxahatchee, FL 33470 Dehghanpisheh Keivan MD - Loxahatchee, FL 33470 Urology Center of Palm Beach - Loxahatchee, FL 33470 Cerullo James A MD - Loxahatchee, FL 33470 Pajo Silao Bebe MD - Loxahatchee, FL 33470 Toller Erin C DO - Loxahatchee, FL 33470 Kurland Sima S DO - Loxahatchee, FL 33470 Pillitteri Rian J MD - Loxahatchee, FL 33470 Doan Bao-Tran MD - Loxahatchee, FL 33470 Napoles-Ruiz Ana Maria MD - Loxahatchee, FL 33470 Bequer Napoleon G MD - Loxahatchee, FL 33470 Konda Prasad MD - Loxahatchee, FL 33470 Goad James J MD - Loxahatchee, FL 33470 Colman Adolfo L MD - Loxahatchee, FL 33470 Liu Edwin MD - Loxahatchee, FL 33470 South FL Neurosurgical - Loxahatchee, FL 33470 Palm Beach Ped Hmtlgy/Oncology - Loxahatchee, FL 33470 Melissa S Singer MD MPH FAAP - Loxahatchee, FL 33470 Cheryl Wayne, MD - Loxahatchee, FL 33470 |
The company Suklenik LA MD provides B2C services in the form of Doctors from its single location in Florida.
1 to 4 employees work for Suklenik LA MD, and the business now earns $500.000 to $999.999 per annum.
Suklenik LA MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Suklenik LA MD, please call LA Suklenik with the phone number (561) 429-2106 or visit its single location at 13005 Southern Boulevard in Loxahatchee, Florida 33470.
The location of the single location can also be found using the coordinates 26.68186,-80.250948.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.